indomethacin has been researched along with Nephrotic Syndrome in 66 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Administration of prednisolone causes an abrupt rise in proteinuria in patients with a nephrotic syndrome." | 9.09 | Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome. ( Koene, RA; Reichert, LJ; Wetzels, JF, 1999) |
| "The effects of indomethacin on urinary protein excretion, levels of serum albumin and renal function were studied prospectively in six patients with systemic lupus erythematosus (SLE) and refractory nephrotic syndrome due to lupus nephritis." | 9.07 | Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapy. ( Cuellar, ML; Espinoza, LR; Jara, LJ; Martinez-Osuna, P; Seleznick, M; Silveira, LH, 1993) |
| "Furosemide is one of the most common drug used to treat anasarca in childhood nephrotic syndrome." | 7.88 | Furosemide-induced tubular dysfunction responding to prostaglandin synthesis inhibitor therapy in a child with nephrotic syndrome. ( Dawman, L; Santhiya, S; Sharma, A; Tiewsoh, K; Varma, TH, 2018) |
| "Two infants with biopsy-proven microcystic Finnish congenital nephrotic syndrome (onset at birth) were treated with a combination of captopril and indomethacin for 2 1/2 and 2 years, respectively; they had a marked reduction of urinary protein excretion without further need for albumin infusions." | 7.69 | Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. ( Bernheim, J; Korzets, Z; Pomeranz, A; Wolach, B, 1995) |
| "In 20 patients with nephrotic syndrome we confirm previous findings of in vitro platelet hyperaggregability to arachidonic acid, and describe similar hyperaggregability to ristocetin." | 7.67 | Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration. ( Bennett, A; Cameron, JS, 1987) |
| "Immediate and longer-term (five-day) effects of indomethacin on proteinuria and renal function were examined in a group of nephrotic subjects with glomerular filtration rates (GFR) that ranged from near normal to moderately impaired." | 7.67 | Reduction of proteinuria by indomethacin in patients with nephrotic syndrome. ( Alavi, N; Bentzel, CJ; Lianos, EA; Mookerjee, BK; Venuto, RC, 1986) |
| "Ten patients with idiopathic minimal lesion nephrotic syndrome were treated with indomethacin." | 7.66 | Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome. ( Fennell, RS; Garin, EH; Richard, GA; Williams, RL, 1978) |
| "In 25 patients with nephrotic syndromes of different origin, indomethacin caused an immediate decrease in glomerular filtration rate (GFR) and urinary protein excretion." | 7.66 | Treatment of the nephrotic syndrome with indomethacin. ( Arisz, L; Brentjens, JR; Donker, AJ; van der Hem, GK, 1978) |
| "Treatment of membranous nephropathy and the nephrotic syndrome with 2 mg/kg/day of indomethacin resulted in prompt and sustained reduction in urinary protein excretion and the loss of edema fluid, which allowed the withdrawal of diuretic therapy and liberalization of salt intake." | 7.66 | Indomethacin and the nephrotic syndrome. ( Abt, AB; Demers, LM; Schoolwerth, AC; Shehadeh, IH, 1979) |
| " In four patients with nephrotic syndrome indomethacin not only reduced proteinuria but also inhibited the natriuretic effect of high doses of frusemide." | 7.65 | Inhibition of frusemide-induced natriuresis by indomethacin in patients with the nephrotic syndrome. ( Koene, RA; Tiggeler, RG; Wijdeveld, PG, 1977) |
| "Administration of prednisolone causes an abrupt rise in proteinuria in patients with a nephrotic syndrome." | 5.09 | Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome. ( Koene, RA; Reichert, LJ; Wetzels, JF, 1999) |
| "The effects of indomethacin on urinary protein excretion, levels of serum albumin and renal function were studied prospectively in six patients with systemic lupus erythematosus (SLE) and refractory nephrotic syndrome due to lupus nephritis." | 5.07 | Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapy. ( Cuellar, ML; Espinoza, LR; Jara, LJ; Martinez-Osuna, P; Seleznick, M; Silveira, LH, 1993) |
| "In a double-blind crossover study in 10 salt-depleted nephrotic patients the reduction of proteinuria was significantly larger during indomethacin 50 mg three times daily than during naproxen 250 or 500 mg three times daily (72 vs." | 5.05 | Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study. ( de Jong, PE; de Zeeuw, D; Donker, AJ; van der Hem, GK; Vriesendorp, R, 1985) |
| "Furosemide is one of the most common drug used to treat anasarca in childhood nephrotic syndrome." | 3.88 | Furosemide-induced tubular dysfunction responding to prostaglandin synthesis inhibitor therapy in a child with nephrotic syndrome. ( Dawman, L; Santhiya, S; Sharma, A; Tiewsoh, K; Varma, TH, 2018) |
| " Angiotensin-converting enzyme (ACE) inhibitors were used to reduce proteinuria in all infants, and one was also treated with indomethacin." | 3.77 | Nephrotic syndrome in infancy can spontaneously resolve. ( Clothier, J; Kim, JJ; Milford, DV; Moghal, N; Sebire, NJ; Trompeter, RS, 2011) |
| "We reviewed the medical records of seven children with congenital nephrotic syndrome (CNS) treated by unilateral nephrectomy, captopril, and indomethacin since 1990." | 3.72 | Management of congenital nephrotic syndrome. ( Kovacevic, L; Reid, CJ; Rigden, SP, 2003) |
| "Two infants with biopsy-proven microcystic Finnish congenital nephrotic syndrome (onset at birth) were treated with a combination of captopril and indomethacin for 2 1/2 and 2 years, respectively; they had a marked reduction of urinary protein excretion without further need for albumin infusions." | 3.69 | Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. ( Bernheim, J; Korzets, Z; Pomeranz, A; Wolach, B, 1995) |
| "In this study we investigated whether the increase in proteinuria induced by an oral protein load may be prevented by the angiotensin-converting enzyme inhibitor (ACEI) captopril in patients with nephrotic syndrome, and whether the effects of captopril on renal haemodynamics and/or glomerular selectivity are comparable to those obtained with the nonsteroidal anti-inflammatory drug (NSAID) indomethacin and the calcium-channel blocker (CaCB) nifedipine." | 3.69 | Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load. ( Allegri, L; Borghetti, A; Buzio, C; Garini, G; Mazzi, A; Mutti, A; Savazzi, G, 1996) |
| "To elucidate the mechanisms by which indomethacin lowers proteinuria, we studied 20 patients with the nephrotic syndrome." | 3.67 | Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans. ( Black, V; Golbetz, H; Myers, BD; Shemesh, O, 1989) |
| "In 20 patients with nephrotic syndrome we confirm previous findings of in vitro platelet hyperaggregability to arachidonic acid, and describe similar hyperaggregability to ristocetin." | 3.67 | Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration. ( Bennett, A; Cameron, JS, 1987) |
| "Immediate and longer-term (five-day) effects of indomethacin on proteinuria and renal function were examined in a group of nephrotic subjects with glomerular filtration rates (GFR) that ranged from near normal to moderately impaired." | 3.67 | Reduction of proteinuria by indomethacin in patients with nephrotic syndrome. ( Alavi, N; Bentzel, CJ; Lianos, EA; Mookerjee, BK; Venuto, RC, 1986) |
| " Indomethacin, diclofenac-sodium and flurbiprofen decreased proteinuria, glomerular filtration rate, plasma renin activity and renal prostaglandin E2 excretion by 59%, 19%, 55% and 68% respectively." | 3.67 | Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs. ( de Jong, PE; de Zeeuw, D; Donker, AJ; Pratt, JJ; van der Hem, GK; Vriesendorp, R, 1986) |
| "The participation of renal prostaglandins in the nephrotic syndrome has been investigated by the measurement of the urinary excretion of prostaglandin E2 (PGE2), renal function and the renin-angiotensin-aldosterone system before, during and after the administration of indomethacin in a group of patients diagnosed as having chronic idiopathic glomerulonephritis with and without nephrotic syndrome." | 3.66 | Participation of renal prostaglandins in the nephrotic syndrome. ( Alcazar, JM; Garcia-Robles, R; Millet, VG; Prieto, C; Rodicio, JL; Ruilope, L; Sancho, J; Tresguerres, JA, 1983) |
| "Ten patients with idiopathic minimal lesion nephrotic syndrome were treated with indomethacin." | 3.66 | Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome. ( Fennell, RS; Garin, EH; Richard, GA; Williams, RL, 1978) |
| "In 25 patients with nephrotic syndromes of different origin, indomethacin caused an immediate decrease in glomerular filtration rate (GFR) and urinary protein excretion." | 3.66 | Treatment of the nephrotic syndrome with indomethacin. ( Arisz, L; Brentjens, JR; Donker, AJ; van der Hem, GK, 1978) |
| " In four patients with nephrotic syndrome indomethacin not only reduced proteinuria but also inhibited the natriuretic effect of high doses of frusemide." | 3.65 | Inhibition of frusemide-induced natriuresis by indomethacin in patients with the nephrotic syndrome. ( Koene, RA; Tiggeler, RG; Wijdeveld, PG, 1977) |
| "The concomitant administration of Indomethacin reduced the biochemical signs of the nephrotic syndrome induced in rats by aminonucleoside; in the rats treated with both drugs a morphological picture suggesting activated function of podocytes was found at the electron microscopic examination of the renal glomerular structures, together with the lesions characteristic of the aminonucleoside nephrosis." | 3.65 | Aminonucleoside nephrosis in rats. Ultrastructural findings in the glomerulus by concomitant influence of indomethacin and aminonucleoside. ( Cioffi, A; Conte, F; D'Amico, GD; Sessa, A, 1975) |
| "Indomethacin in vitro has no effect." | 1.26 | Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat. ( Barratt, TM; Garin, EH, 1982) |
| "70 cases of focal glomerulosclerosis (FGS) followed for periods ranging from 1 to 24 years are reported." | 1.26 | Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. ( Alphonse, JC; Beaufils, H; Guedon, J; Legrain, M, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (72.73) | 18.7374 |
| 1990's | 12 (18.18) | 18.2507 |
| 2000's | 4 (6.06) | 29.6817 |
| 2010's | 2 (3.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Varma, TH | 1 |
| Sharma, A | 1 |
| Santhiya, S | 1 |
| Dawman, L | 1 |
| Tiewsoh, K | 1 |
| Le Roy, V | 1 |
| Delmas, Y | 1 |
| Verdoux, H | 1 |
| Kim, JJ | 1 |
| Clothier, J | 1 |
| Sebire, NJ | 1 |
| Milford, DV | 1 |
| Moghal, N | 1 |
| Trompeter, RS | 1 |
| Kovacevic, L | 1 |
| Reid, CJ | 1 |
| Rigden, SP | 1 |
| Hattori, M | 1 |
| Michielsen, P | 1 |
| Lambert, PP | 1 |
| Garin, EH | 3 |
| Richard, GA | 2 |
| Ruilope, L | 1 |
| Millet, VG | 1 |
| Alcazar, JM | 1 |
| Prieto, C | 1 |
| Tresguerres, JA | 1 |
| Garcia-Robles, R | 1 |
| Sancho, J | 1 |
| Rodicio, JL | 1 |
| Baumelou, A | 1 |
| LeGrain, M | 2 |
| Kleinknecht, C | 1 |
| Broyer, M | 1 |
| Gubler, MC | 1 |
| Palcoux, JB | 1 |
| Zawada, ET | 1 |
| Barratt, TM | 1 |
| Pomeranz, A | 1 |
| Wolach, B | 1 |
| Bernheim, J | 2 |
| Korzets, Z | 1 |
| Duda, SH | 1 |
| Raible, RT | 1 |
| Risler, T | 1 |
| Huppert, PE | 1 |
| Brambs, HJ | 1 |
| Gregor, M | 1 |
| Kooijmans-Coutinho, MF | 1 |
| Tegzess, AM | 1 |
| Bruijn, JA | 1 |
| Florijn, KW | 1 |
| van Es, LA | 1 |
| van der Woude, FJ | 1 |
| Espinoza, LR | 1 |
| Jara, LJ | 1 |
| Martinez-Osuna, P | 1 |
| Silveira, LH | 1 |
| Cuellar, ML | 1 |
| Seleznick, M | 1 |
| Garini, G | 1 |
| Mazzi, A | 1 |
| Buzio, C | 1 |
| Mutti, A | 1 |
| Allegri, L | 1 |
| Savazzi, G | 1 |
| Borghetti, A | 1 |
| Hanson, B | 1 |
| D'Hondt, A | 1 |
| Depierreux, M | 1 |
| Lustman, F | 1 |
| Kacprzyk, F | 1 |
| Chrzanowski, W | 1 |
| Kubala, L | 1 |
| Orłowski, Z | 1 |
| Reichert, LJ | 1 |
| Koene, RA | 2 |
| Wetzels, JF | 1 |
| Heaton, PA | 1 |
| Smales, O | 1 |
| Wong, W | 1 |
| Licht, C | 1 |
| Eifinger, F | 1 |
| Gharib, M | 1 |
| Offner, G | 1 |
| Michalk, DV | 1 |
| Querfeld, U | 1 |
| Lindeman, RD | 1 |
| Tiggeler, RG | 2 |
| Hulme, B | 1 |
| Wijdeveld, PG | 3 |
| Kshirsagar, NA | 1 |
| Shah, BP | 1 |
| Paul, T | 1 |
| Acharya, VN | 1 |
| Sattur, PB | 1 |
| Sheth, UK | 1 |
| Williams, RL | 1 |
| Fennell, RS | 1 |
| Beaufils, H | 1 |
| Alphonse, JC | 1 |
| Guedon, J | 1 |
| Donker, AJ | 5 |
| Brentjens, JR | 3 |
| van der Hem, GK | 5 |
| Arisz, L | 3 |
| Shehadeh, IH | 1 |
| Demers, LM | 1 |
| Abt, AB | 1 |
| Schoolwerth, AC | 1 |
| Birnbaum, M | 1 |
| Meijer, S | 1 |
| Sessa, A | 1 |
| Conte, F | 1 |
| Cioffi, A | 1 |
| D'Amico, GD | 1 |
| Thiele, KG | 1 |
| Bergstein, JM | 1 |
| Kutyrina, IM | 1 |
| Rogov, VA | 1 |
| Zverev, KV | 1 |
| Heeg, JE | 1 |
| de Jong, PE | 4 |
| Vriesendorp, R | 4 |
| de Zeeuw, D | 4 |
| Golbetz, H | 1 |
| Black, V | 1 |
| Shemesh, O | 1 |
| Myers, BD | 1 |
| Matsumoto, K | 1 |
| Carmichael, J | 1 |
| Shankel, SW | 1 |
| Kirschenbaum, MA | 1 |
| Liebross, BA | 1 |
| Serros, ER | 1 |
| Bennett, A | 1 |
| Cameron, JS | 1 |
| Al-Waili, NS | 1 |
| van Hooff, JP | 1 |
| Leunissen, KM | 1 |
| Havenith, MG | 1 |
| Bosman, FT | 1 |
| Alavi, N | 1 |
| Lianos, EA | 1 |
| Venuto, RC | 1 |
| Mookerjee, BK | 1 |
| Bentzel, CJ | 1 |
| Pratt, JJ | 1 |
| Boiskin, I | 1 |
| Saven, A | 1 |
| Mendez, M | 1 |
| Raja, RM | 1 |
| Koopmans, PP | 1 |
| Sarre, H | 1 |
| Cagli, V | 1 |
| Zech, P | 1 |
| Richard, P | 1 |
| Blanc-Brunat, N | 1 |
| Labeeuw, M | 1 |
| Colon, S | 1 |
| Pozet, N | 1 |
| Dupont, E | 1 |
| Fries, D | 1 |
| Traeger, J | 1 |
| Black, DA | 1 |
| Genova, R | 1 |
| Tamborino, G | 1 |
| Lagrue, G | 1 |
| Masbernard, A | 1 |
| Giudicelli, C | 1 |
| Hirbec, G | 1 |
| Bohle, A | 1 |
| Fischbach, H | 1 |
| Wehner, H | 1 |
| Woerz, U | 1 |
| Edel, HH | 1 |
| Kluthe, R | 1 |
| Scheler, F | 1 |
| Campanacci, L | 1 |
| Gambari, P | 1 |
| Castellani, A | 1 |
| Huber, W | 1 |
| Rowecka-Trzebicka, K | 1 |
| Wojnarowski, M | 1 |
| Valderrábano Quintana, F | 1 |
| Alcázar de la Ossa, JM | 1 |
| Romojaro Vázquez, A | 1 |
| Torres Torres, G | 1 |
| Tojo, S | 1 |
| Narita, M | 1 |
| Hirose, K | 1 |
| Varese, LA | 1 |
| Antoniola, P | 1 |
| Murisasco, A | 1 |
| Picon, G | 1 |
| Hebreard, J | 1 |
| Sansot, M | 1 |
| Aubert, L | 1 |
| Taramasco, J | 1 |
| Mrtin, J | 1 |
| Manassero, L | 1 |
8 reviews available for indomethacin and Nephrotic Syndrome
| Article | Year |
|---|---|
[Chronic renal complications induced by lithium].
Topics: Amiloride; Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Bipolar Disorder; Diabetes Ins | 2009 |
[Congenital nephrotic syndrome].
Topics: Albumins; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Genes, Recessive; Hum | 2004 |
Renal consequences of nonsteroidal antiinflammatory drugs.
Topics: Acidosis; Acute Kidney Injury; Aged; Anti-Inflammatory Agents; Bartter Syndrome; Female; Humans; Hyp | 1982 |
[Kidney and pregnancy].
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Chloramphenicol; Creatin | 1976 |
Prostaglandin inhibitors in the treatment of nephrotic syndrome.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Humans; Indomethacin; Neph | 1991 |
Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function.
Topics: Anti-Inflammatory Agents; Aspirin; Epoprostenol; Fenoprofen; Glafenine; Glomerular Filtration Rate; | 1985 |
Effects of nonsteroidal anti-inflammatory drugs on proteinuria.
Topics: Anti-Inflammatory Agents; Hemodynamics; Humans; Indomethacin; Kidney; Nephrotic Syndrome; Proteinuri | 1986 |
Pathophysiological and clinical aspects of the interaction between non-steroidal anti-inflammatory drugs (NSAID) and diuretics.
Topics: Anti-Inflammatory Agents; Diuretics; Drug Interactions; Drug Therapy, Combination; Heart Failure; Hu | 1985 |
9 trials available for indomethacin and Nephrotic Syndrome
| Article | Year |
|---|---|
Irreversible renal failure after indomethacin in steroid-resistant nephrosis.
Topics: Child; Chlorambucil; Clinical Trials as Topic; Female; Glomerular Filtration Rate; Humans; Indometha | 1980 |
Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapy.
Topics: Adult; Creatinine; Female; Humans; Indomethacin; Kidney; Lupus Nephritis; Middle Aged; Nephrotic Syn | 1993 |
[Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dipyridamole; Female; Glomerulosclerosis | 1997 |
Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; beta 2-Microglobulin | 1999 |
Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Drug | 1990 |
Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Glomerular Filtration Rate; Huma | 1985 |
Therapeutic trials in renal disease.
Topics: Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Glomerulonephritis; Humans; Indomethacin; | 1972 |
[Indomethacin the treatment of glomerular nephropathies].
Topics: Adult; Child; Clinical Trials as Topic; Evaluation Studies as Topic; Glomerulonephritis; Humans; Ind | 1973 |
Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Blood Urea Nitrogen; Chronic Disease; Clinical Trials a | 1974 |
49 other studies available for indomethacin and Nephrotic Syndrome
| Article | Year |
|---|---|
Furosemide-induced tubular dysfunction responding to prostaglandin synthesis inhibitor therapy in a child with nephrotic syndrome.
Topics: Alkalosis; Bartter Syndrome; Child, Preschool; Cyclooxygenase Inhibitors; Diuretics; Female; Furosem | 2018 |
Nephrotic syndrome in infancy can spontaneously resolve.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Stero | 2011 |
Management of congenital nephrotic syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Captopril; Combin | 2003 |
[Effects of corticosteroid and indomethacin treatment on proteinuria].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Glomerulonephritis; Humans; Indomethacin; Male; M | 1967 |
Prostaglandin synthesis inhibitors and primary antibody response in experimental nephrotic syndrome.
Topics: Animals; Antibody-Producing Cells; Aspirin; Hemolytic Plaque Technique; Indomethacin; Isoantibodies; | 1984 |
Participation of renal prostaglandins in the nephrotic syndrome.
Topics: Adolescent; Adult; Dinoprostone; Female; Glomerulonephritis; Humans; Indomethacin; Kidney; Male; Mid | 1983 |
Medical nephrectomy with anti-inflammatory non-steroidal drugs.
Topics: Adult; Humans; Indomethacin; Kidney; Kidney Failure, Chronic; Male; Nephrotic Syndrome | 1982 |
Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat.
Topics: Animals; Indomethacin; Lymphocyte Activation; Male; Nephrotic Syndrome; Proteinuria; Puromycin Amino | 1982 |
Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin.
Topics: Captopril; Humans; Indomethacin; Infant, Newborn; Kidney; Kidney Failure, Chronic; Kidney Transplant | 1995 |
[Therapeutic bilateral renal artery embolization in the nephrotic syndrome].
Topics: Amyloidosis; Captopril; Cardiomyopathies; Contraindications; Creatinine; Crohn Disease; Drug Therapy | 1994 |
Indomethacin treatment of recurrent nephrotic syndrome and focal segmental glomerulosclerosis after renal transplantation.
Topics: Adult; Female; Glomerulosclerosis, Focal Segmental; Humans; Indomethacin; Kidney Transplantation; Ma | 1993 |
Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflam | 1996 |
Nephrotic syndrome after norfloxacin.
Topics: Aged; Amlodipine; Anti-Infective Agents; Antihypertensive Agents; Clonidine; Creatinine; Diuretics; | 1996 |
Congenital nephrotic syndrome responsive to captopril and indometacin.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Captopril; Female | 1999 |
A stepwise approach to the treatment of early onset nephrotic syndrome.
Topics: Age of Onset; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Blo | 2000 |
Drug treatment of the chronic idiopathic glomerulopathies.
Topics: Adrenal Cortex Hormones; Alkylating Agents; B-Lymphocytes; Chronic Disease; Dipyridamole; Folic Acid | 1977 |
Effect of indomethacin on glomerular permeability in the nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; | 1979 |
Effect of nonsteroidal anti-inflammatory agents and diuretics in nephrotic syndrome patients.
Topics: Anti-Inflammatory Agents; Diuretics; Drug Interactions; Drug Therapy, Combination; Furosemide; Glome | 1979 |
Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Humans; Indomethacin; Nephrotic Syndrome; Proteinuria | 1978 |
Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Child; Female; Follow-Up St | 1978 |
Treatment of the nephrotic syndrome with indomethacin.
Topics: Angiotensin II; Diet, Sodium-Restricted; Glomerular Filtration Rate; Humans; Indomethacin; Kidney; N | 1978 |
Indomethacin and the nephrotic syndrome.
Topics: Adult; Basement Membrane; Humans; Indomethacin; Male; Nephrotic Syndrome; Prostaglandins E; Prostagl | 1979 |
Inhibition of frusemide-induced natriuresis by indomethacin in patients with the nephrotic syndrome.
Topics: Adult; Aged; Female; Furosemide; Humans; Indomethacin; Male; Middle Aged; Natriuresis; Nephrotic Syn | 1977 |
[A patient with edemas].
Topics: Adult; Albumins; Edema; Female; Furosemide; Glomerular Filtration Rate; Humans; Indomethacin; Infusi | 1976 |
Aminonucleoside nephrosis in rats. Ultrastructural findings in the glomerulus by concomitant influence of indomethacin and aminonucleoside.
Topics: Animals; Basement Membrane; Cell Membrane Permeability; Drug Antagonism; Female; Indomethacin; Injec | 1975 |
[Special pharmacotherapy of primary glomerulonephritis in the adult].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anticoagulants; Azathioprine; Cyclophosphamide; Dipyrid | 1975 |
The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome.
Topics: Adolescent; Adult; Depression, Chemical; Female; Follow-Up Studies; Glomerular Filtration Rate; Huma | 1976 |
[The renal systems regulating water-electrolyte balance in the nephrotic syndrome].
Topics: Adolescent; Adult; Chronic Disease; Dopamine; Edema; Glomerular Filtration Rate; Heparin; Humans; In | 1991 |
Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans.
Topics: Adolescent; Adult; Dextrans; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; | 1989 |
Decreased production of interleukin-1 by monocytes from patients with lipoid nephrosis.
Topics: Adolescent; Adult; Female; Humans; In Vitro Techniques; Indomethacin; Interleukin-1; Lipopolysacchar | 1989 |
Effect of indomethacin on proteinuria in rats with autologous immune complex nephropathy.
Topics: Animals; Autoimmune Diseases; Glomerular Filtration Rate; Immune Complex Diseases; Indomethacin; Kid | 1985 |
Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration.
Topics: Adult; Antigens; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Factor VIII; Humans; Immunogl | 1987 |
Three cases of nephrotic syndrome treated by indomethacin.
Topics: Adult; Female; Humans; Indomethacin; Male; Middle Aged; Nephrotic Syndrome | 1988 |
Cyclosporine and other therapy-resistant nephrotic syndrome.
Topics: Adult; Cyclosporins; Drug Resistance; Humans; Indomethacin; Male; Nephrotic Syndrome; Proteinuria | 1988 |
Reduction of proteinuria by indomethacin in patients with nephrotic syndrome.
Topics: Dinoprostone; Glomerular Filtration Rate; Humans; Indomethacin; Nephrotic Syndrome; Prostaglandins E | 1986 |
Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents; Diclofenac; Dinoprostone; Flurbiprofen; Glomerular Filtration Rate; | 1986 |
Indomethacin and the nephrotic syndrome.
Topics: Humans; Indomethacin; Male; Middle Aged; Nephrotic Syndrome | 1987 |
[Approach to the treatment of intractable nephrotic syndrome].
Topics: Cyclophosphamide; Dipyridamole; Glomerulonephritis; Humans; Immunosuppressive Agents; Indomethacin; | 1986 |
Some clinical and therapeutic aspects of the nephrotic syndrome in the adult (with special emphasis on the effects of indomethacin and related substances).
Topics: Adrenocorticotropic Hormone; Adult; Cyclophosphamide; Female; Humans; Indomethacin; Male; Microscopy | 1971 |
[Membraneous-proliferating glomerulonephritis associated with the nephrotic syndrome].
Topics: Adrenocorticotropic Hormone; Azathioprine; Contraception; Cyclophosphamide; Diet Therapy; Dietary Pr | 1971 |
[Therapy of nephrotic syndrome].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Cyclophosphamide; Diet Therapy; | 1971 |
[Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Antimalarials; Azathioprine; Biopsy; Chlorambucil; | 1972 |
Minimal change lesion with nephrotic syndrome and focal glomerular sclerosis. (Variations of minimal proliferative intercapillary glomerulonephritis with the nephrotic syndrome).
Topics: Adolescent; Adult; Aged; Capillaries; Cell Count; Child; Child, Preschool; Endothelium; Epithelial C | 1974 |
[Indomethacin in the therapy of prolonged or chronic glomerulonephritis and of the nephrotic syndrome].
Topics: Adolescent; Adult; Biopsy; Child; Chronic Disease; Glomerulonephritis; Humans; Indomethacin; Kidney; | 1972 |
[Renal changes in Schönlein-Henoch disease in the light of our own observations].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Female; Glomerulonephritis; Humans; Immunosuppress | 1971 |
[Indomethacin in the treatment of the nephrotic syndrome. Preliminary results].
Topics: Adolescent; Adult; Child; Female; Humans; Immunosuppressive Agents; Indomethacin; Male; Nephrotic Sy | 1971 |
[Refractory nephrotic syndrome].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Child; Humans; Indomethacin; Nephrotic Synd | 1969 |
[On the use of indomethacin in the treatment of renal diseases in childhood].
Topics: Blood Proteins; Child; Child, Preschool; Diuresis; Female; Glomerulonephritis; Humans; Indomethacin; | 1970 |
[Indomethacin in the treatment of the nephrotic syndrome and residuaproteinuria].
Topics: Humans; Indomethacin; Nephrotic Syndrome; Proteinuria | 1967 |